By treating content as data, rather than documents, most of the problems inherent in monolithic documents are remedied.
I had a really interesting conversation today with my friend, Cheryl Landes. For those of you who don’t know Cheryl, she is a content organizer extraordinaire. Cheryl has tremendous experience – particularly in the indexing arena. And for those of you who don’t have an appreciation for the fine art
If you work with content long enough, you’ll eventually run into two words that sound like they belong together: taxonomy and terminology.
Content reuse is the practice of creating one piece of content and then using that piece of content everywhere you need it. A reused piece of content is created, finalized, translated, managed, stored, and retired one, and only one, time.
Unlock solutions for content and process challenges. Differentiate and enhance with expert insights. Elevate your content strategy now!
In pharmaceutical and biotech regulatory document development, your content strategy – the business plan for how you create, manage, and deliver content – significantly impacts your ability to innovate, comply with regulations, and ultimately, bring new medicines to market.
Our customers often face complex content problems that hinder their efficiency, scalability, and customer satisfaction. These challenges cost the enterprise money, time, and risk.
